Liquidia Corporation Common Stock vs Magna International Inc. Common Stock — how do they compare? Liquidia Corporation Common Stock trades at $33.47 (market cap $3.04B), while Magna International Inc. Common Stock trades at $64.38 (market cap $17.25B). The key difference: Magna International Inc. Common Stock is far larger — about 5.7× Liquidia Corporation Common Stock's market cap, and Magna International Inc. Common Stock pays a 3.07% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Magna International Inc. Common Stock for 6 Days on average.
| LQDA | MGA | |
|---|---|---|
Market Cap | $3.04B | $17.25B |
Volume | 21,111,778 | 894,575 |
Sector | Health | Consumer Cyclical |
52-Week High | $91.03 | $73.05 |
52-Week Low | $22.02 | $44.65 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.94B | $22.29B |
Dividend Yield | — | 3.07% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Magna International (MGA) trades at $65.31, up 2.75% with a bullish technical signal. The stock shows strong earnings momentum with three consecutive quarterly beats and trades at attractive valuations with P/E of 24.01 and P/S of 0.43. Recent news highlights margin expansion and international growth opportunities, while cash flow remains positive despite increased capital returns.
MGA presents a favorable risk-reward profile with analyst consensus target of $69.20 (5.9% upside) and 43% buy ratings. Key catalysts include Q3 2026 earnings on October 30 and continued margin improvement, though risks include flat auto production and potential tariff impacts on North American operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →